Hasil Pencarian  ::  Simpan CSV :: Kembali

"ABSTRAKTatalaksana kanker di suatu rumah sakit tidak dapat berjalan baik tanpa tersedianya data kanker yang baik. Registrasi kanker berbasis rumah sakit di RSUPN Cipto Mangunkusumo mulai diimplemetasikan kembali sejak ditanda tanganinya surat keputusan bersama terkait onkologi center oleh Direktur RSUPN Cipto Mangunkusumo dengan Dekan Fakultas Kedokteran Universitas Indonesia pada bulan April 2016. Penelitian ini merupakan penelitian deskriptif observasional dalam implementasi registrasi kanker dan evaluasi hasil data yang dihasilkannya. Pencatatan pada registrasi kanker menggunakan formulir SRiKandI dan diinput kedalam server menggunakan program CanReg5. Data yang dikumpulkan adalah data kanker pada tahun 2013 antara lain data data demografi, data klinis, data sumber, dan data follow-up. Permasalahan implementasi terjadi pada. Tim registrasi kanker mengolah 886.086 data mentah menjadi 5.554 data bersih pasien kanker tahun 2013 dan didapatkan 10 besar pasien kanker terbanyak antara lain Kanker Payudara, Kanker Serviks, Leukemia, Kolorektal, Limfoma, Nasofaring, Ovarium, Tiroid, Hepatoma dan Kulit. Penegakan diagnosis 73 menggunakan pemeriksaan mikroskopik Microscopic Verification MV .

---

ABSTRACTCancer management in a hospital can rsquo t be done properly without the availability of cancer data. Hospital based cancer registry in Cipto Mangunkusumo began to be implemented since the signing of a joint decree of the oncology center by the Director of Cipto Mangunkusumo Hospital and the Dean of the Faculty of Medicine University of Indonesia in April 2016. Cancer registration use SRiKandI form as a template for data collection and inputted into the server using CanReg5 program. This study was an observational descriptive study in the implementation and evaluation of cancer registration data. The collected data is the data of cancer from year 2013, including demographic data, clinical data, source data, and follow up data. Implementation problems occurred in the bureaucracy, medical records, human resources, the use of Electronic Health Record EHR and CanReg5 program. Cancer registration team process 886.086 raw data into a 5.554 clean data of cancer patients in 2013 and found 10 highest number of cancer patients among others are Breast Cancer, Cervical Cancer, leukemia, colorectal, lymphoma, nasopharyngeal, ovary, thyroid, and skin hepatoma. Diagnosis of 73 using a microscopic examination Microscopic Verification MV ."

"Latar Belakang Kanker adalah penyebab kematian secara global dan merupakan penyebab utama kematian pada anak. Dampaknya besar pada anak-anak di negara berpenghasilan rendah dengan tingkat kelangsungan hidup di bawah 30% akibat diagnosis terlambat, pengobatan yang tidak memadai, dan diagnosis tidak tepat. Hingga saat ini, belum ada publikasi terkait epidemiologi kanker anak pada pasien RSCM. Metode Penelitian ini adalah studi deskriptif mengenai epidemiologi kanker pada anak di Rumah Sakit dr. Cipto Mangunkusumo pada tahun 2017 sampai dengan 2022. Penelitian ini menggunakan rekam medis dari Departemen Ilmu Kesehatan Anak RSCM. Hasil Di RSCM, terdapat 1699 kasus kanker anak pada tahun 2017-2022. Sepuluh kasus kanker anak tertinggi adalah leukemia limfositik akut (630 kasus, 39,5%), diikuti oleh leukemia mieloid akut (311 kasus, 19,5%), retinoblastoma (221 kasus, 13,8%), tumor tulang (100 kasus, 6,3%), neuroblastoma (81 kasus, 5,1%), limfoma non-Hodgkin (73 kasus, 4,6%), rhabdomiosarcoma (70 kasus, 4,4%), leukemia mieloid kronik (54 kasus, 3,4%), hepatoblastoma (31 kasus, 2,0%), dan tumor otak (23 kasus, 1,5%). Pasien laki-laki memiliki kemungkinan 1,3 kali lebih tinggi untuk mengalami kanker (971 kasus, 57,1%). Pasien dengan kategori usia 0-5 tahun mempunyai prevelansi kanker paling tinggi (881 kasus, 51,9%), dan kebanyakan berdomisili di DKI Jakarta (552 kasus, 32,5%). Luaran pasien kebanyakan pada tahap loss-to-follow-up (664 kasus, 39,0%), dan 2021 adalah tahun dengan kasus terbanyak (335 kasus, 19,7%). Kesimpulan Dengan mengetahui epidemiologi kanker anak di RSCM, dapat dibuat sebuah strategi untuk prioritas penanganan kasus kanker tertinggi pada anak. Lalu, menjaga database yang terkini dengan melakukan follow-up secara berkala untuk mendapatkan data yang akurat mengenai relaps, kematian, penyembuhan, dan lost-to-follow-up dan dibutuhkan sebuah studi epidemiologi multi-senter yang mencakup prevalensi kanker anak di Indonesia untuk memperbaiki penanganan kanker anak.

---

Introduction Cancer is a leading global cause of death, particularly among children. Its impact is substantial in low-income countries, where survival rates are below 30% due to delayed diagnosis, inadequate treatment, and misdiagnosis. To date, there have been no publications regarding the epidemiology of childhood cancer in RSCM patients. Method This research is a descriptive study on the Epidemiology of Childhood Cancer at dr. Cipto Mangunkusumo Hospital from 2017 to 2022. This study utilizes medical records from the Department of Pediatrics at RSCM. Results At RSCM, there were 1699 cases of childhood cancer from 2017 to 2022. The top ten childhood cancer cases were acute lymphoblastic leukemia (630 cases, 39.5%), followed by leukemia mieloid akut(311 cases, 19.5%), retinoblastoma (221 cases, 13.8%), bone tumors (100 cases, 6.3%), neuroblastoma (81 cases, 5.1%), non-Hodgkin lymphoma (73 cases, 4.6%), rhabdomyosarcoma (70 cases, 4.4%), chronic myeloid leukemia (54 cases, 3.4%), hepatoblastoma (31 cases, 2.0%), and brain tumors (23 cases, 1.5%). Male patients have a 1,3 times higher likelihood of experiencing cancer (971 cases, 57.1%). Patients in the 0-5 age group have the highest cancer prevalence (881 cases, 51.9%), and most of them reside in Jakarta (552 cases, 32.5%). The majority of patients had an outcome classified as loss-to-follow-up (664 cases, 39.0%), and 2021 had the highest number of cases (335 cases, 19.7%). Conclusion By understanding the epidemiology of childhood cancer at RSCM, a strategy can be developed to prioritize the management of the highest cases of childhood cancer. Maintaining an up-to-date database by conducting regular follow-ups is essential to obtain accurate data on relapses, deaths, recoveries, and cases lost to follow-up. A multicenter epidemiological study that includes the prevalence of childhood cancer in Indonesia is needed to improve the management of childhood cancer."

"Kanker payudara merupakan jenis kanker terbanyak diantara wanita Indonesia. Pada tahun 2013, belum diketahui faktor apa yang berhubungan dengan kanker payudara pada pasien di Rumah Sakit Umum Pusat Nasional (RSUPN) dr. Cipto Mangunkusumo. Tujuan penelitian ini adalah untuk mengetahui faktor apa saja yang berhubungan dengan kanker payudara. Desain studi yang digunakan adalah kasus kontrol. Data dikumpulkan dengan menggunakan kuesioner yang diambil dari pasien rawat jalan RSUPN dr. Cipto Mangunkusumo khususnya dari poli bedah. Sampel terdiri dari 117 kasus kanker payudara dan 119 kontrol (pasien lain di poli bedah yang tidak menderita kanker payudara). Hasil penelitian menunjukkan adanya peningkatan risiko kanker payudara pada umur 35-44 tahun (OR=3,370, 95% CI=1,390-8,170), dan 45-54 tahun (OR= 3,690, 95% CI=1,558-8,739) dibandingkan umur <35 tahun, umur menarche <12 tahun (OR=2,962, 95% CI=1,352-6,488) dibandingkan ≥12 tahun, adanya riwayat keturunan kanker payudara (OR=3,035, 95% CI=1,286-7,165) dan adanya keluarga tingkat 1 yang menderita kanker payudara (OR=3,854, 95% CI= 1,031-14,411) dibandingkan tidak ada riwayat keturunan kanker payudara sama sekali. Sementara itu efek protektif yang signifikan melindungi kanker payudara adalah menyusui anak selama ≥6 tahun (OR= 0,419, 95% CI=0,202-0,868) dibandingkan menyusui anak selama <2 tahun. Perlu adanya peningkatan promosi kesehatan mengenai faktorfaktor yang berhubungan dengan kanker payudara kepada masyarakat.

---

Breast cancer is the most common cancer among women in Indonesia. In 2013,it remains unknown factors that cause breast cancer on patients of Rumah Sakit Umum Pusat Nasional (RSUPN) dr. Cipto Mangunkusumo. The purpose of this study is to determine what factors are associated with breast cancer. Study design was case-control. Data were collected using questionnaires from the unhospitalized patients RSUPN dr. Cipto Mangunkusumo especially in Department of Surgery. Sample of 117 breast cancer cases and 119 control (other unhospitalized patients in Department of Surgery does not have breast cancer) were recruited. The results found increasing risk due to age of 35-44 (OR=3,370,95% CI=1,390-8,170), and age of 45-54 (OR= 3,690, 95% CI=1,558-8,739) compared to age of <35, age at menarche of <12 (OR=2,962, 95% CI=1,352-6,488) compared to age at menarche of ≥12, family history of breast cancer(OR=3,035, 95% CI=1,286-7,165) and family history of breast cancer in first degree relatives (OR=3,854, 95% CI= 1,031-14,411) compared to them with no family history of breast cancer. Meanwhile the significant protective effect that protect breast cancer is breastfeeding for ≥6 years (OR= 0,419, 95% CI=0,202-0,868) compared to breastfeeding for <2 years.There is need to increase health promotion regarding the factors associated with breast cancer to the public."

"ABSTRAKNama : MegawatiProgram Studi : EpidemiologiJudul : Kesintasan Pasien Kanker Payudara Berdasarkan Keterlambatan Pengobatandi Rumah Sakit Umum Cipto MangunkusumoPembimbing : Prof. Dr. dr. Bambang Sutrisna, MHSc Epidemiology AbstrakKanker payudara masih mendominasi penyakit kanker pada wanita di duniatermasuk di Indonesia. Rumah Sakit Cipto Mangunkusumo sebagai rumah sakitrujukan nasional dengan jumlah kasus terus meningkat setiap tahunnya.Sebagian besar kasus ditemukan pada stadium lanjut dan mengalamiketerlambatan pengobatan lebih dari 60 hari setelah didiagnosis. Keterlambatanpengobatan diduga berpengaruh terhadap kesintasan pasien kanker payudara.Oleh karena itu penelitian ini dilakukan untuk menilai hubungan keterlambatanpengobatan dengan kesintasan pasien kanker payudara di RSCM. Desain studipenelitian adalah kohort retrospektif dengan mengamati 584 pasien yangmemenuhi kriteria inklusi. Pengamatan dilakukan mulai dari 1 Januari 2011sampai Desember 2017. Data dianalisis secara univariat, bivariat dengan ujilogrank, dan multivariat dengan cox regresi. Hasil penelitian menunjukkan dari584 pasien yang dianalisis ditemukan besarnya risiko terjadinya kematiansebesar 1,27 kali lebih cepat pada pasien yang mengalami keterlambatanpengobatan lebih dari 60 hari dibandingkan dengan pasien yang mendapatkanpengobatan kurang dari 60 hari HR=1,27; 95 CI;0,99 ndash; 1,64 setelah dikontrolstadium klinis, status pernikahan, dan status hormon reseptor estrogen.Perbedaan kesintasan antara pasien yang terlambat lebih dari 60 hari setelahdidiagnosis adalah sebesar 7 pada tahun kelima. Berdasarkan penelitian inidapat disimpulkan bahwa keterlambatan pengobatan lebih dari 60 hari setelahdidiagnosis mempengaruhi kesintasan pasien kanker payudara sehinggapentingnya edukasi kepada pasien dan keluarga untuk tidak menundapengobatan setelah didiagnosis.Kata kunci: keterlambatan pengobatan; kesintasan; kanker payudara

---

ABSTRACTName MegawatiStudy Program EpidemiologiTitle Survival of Breast Cancer based on Delay treatment at CiptoMangunkusumo HospitalCounsellor Prof. Dr. dr. Bambang Sutrisna, MHSc Epidemiology Breast cancer still dominates cancer in women in the world including inIndonesia. Cipto Mangunkusumo Hospital as a national referral hospitalwith the number of cases continues to increase every year. Most of the caseswere found at an advanced stage and experienced treatment delays morethan 60 days after diagnosis. Treatment delays are thought to affect thesurvival of breast cancer patients. Therefore, this study was conducted toassess the relationship of delayed treatment with survival of breast cancerpatients at RSCM. The study design was a retrospective cohort by observing584 patients who met the inclusion criteria. Observations were done from 1January 2011 to December 2017. Data were analyzed univariat, bivariatewith logrank test, and multivariate with cox regression. The results of thestudy showed that the 584 patients analyzed found that the risk of death was1.27 times faster in patients who experienced treatment delay more than 60days compared with patients who received treatment less than 60 days HR 1.27 95 CI 0,99 1.92 after controlled marital status, hormonereceptor estrogen, and clinical stage. The difference in survival betweentheir patients who were late more than 60 days after the diagnosis was 7 in the fifth year. Based on this research, it can be concluded that the delayof treatment influences survival of breast cancer patients so that theimportance of education to the patient and family to immediately performtreatment after diagnosis.Keywords Delay treatment Survival Breast Cancer"

"[Tujuan: Untuk mengetahui profil pasien kanker rektum di Departemen Radioterapi RSCM. Metode: Dilakukan penelitian restrospektif deskriptif analitik terhadap 144 pasien kankerrektum yang menjalani radiasi di Departemen Radioterapi RSCM periode Januari 2009Januari2014, dilihat karakteristik pasien dan tumor. Respons radiasi dinilai menggunakanmetode RECIST 1.1. Hubungan antara OTT dan DTT dengan respons radiasi dinilai dengankorelasi Spearman dan analisis kesintasan dihitung dengan kurva Kaplan Meier. Hasil: Pasien laki-laki sebesar 65.9%, median usia 53 (23-81) tahun dengan mayoritas beradapada kelompok usia 50-59 tahun. Tipe histopatologi terbanyak adalah adenokarsinoma(88.8%) dan pasien paling banyak datang dengan stadium IIIB (25.0%). Kemoradiasidilakukan pada 29.8% pasien, dengan toksisitas radiasi akut terbanyak adalah pada kulit(derajat I) sebesar 20.1%. Respons radiasi yang dinilai dengan metode RECIST 1.1menunjukkan respons terbanyak adalah stabil (71.4%). Tidak ditemukan korelasi antara OTTdan DTT dengan respons radiasi. Dari 118 pasien, didapatkan analisis kesintasan keseluruhan3 dan 5 tahun masing-masing adalah 65% dan 45% dengan median survival 59 bulan. Padakelompok pasien yang menjalani radiasi panjang, analisis kesintasan keseluruhan 3 dan 5tahun masing-masing adalah masing-masing 91% dan 78%. Kesimpulan: Karakteristik pasien rektum di Departemen Radioterapi RSCM yang berbedadengan berbagai studi sebelumnya hanya usia. Respons radiasi yang paling banyak dijumpai adalah stabil. Tidak ditemukan korelasi antara OTT dan DTT dengan respons radiasi.;Purpose: To obtain the profile of rectal cancer patients in Department of Radiotherapy, National General Hospital of Cipto Mangunkusumo.Method: A restrospective study was conducted over 144 rectal cancer patients undergone radiation therapy in Department of Radiotherapy, National General Hospital of CiptoMangunkusumo during period of January 2009 to January 2014. The characteristics ofpatients and tumour were assessed. The radiation response was evaluated with the RECIST1.1 method. The correlation between OTT and DTT with radiation response was analyzedwith Spearman?s correlation and the survival analysis was determined using Kaplan-Meiercurve. Result: The majority of patients were male (65.9%), with median age of 53 (23-81) years oldwhere most patients belonged to age group of 50-59 years old. The most frequenthistopathologic type found was adenocarcinoma (88.8%) with most patients were in stageIIIB (25.0%). Chemoradiation was performed in 29.8% of patients, and grade I skin toxicitywas the most frequent acute side effect of radiation found (20.1%). Radiation responseassessed with the RECIST 1.1 method showed stable disease as the mostly seen response(71.4%). There was no correlation found between OTT and DTT with radiation response.Overall survival from 118 patients for 3 and 5 years were 65% and 45%, respectively, withmedian survival of 59 months. In the group of patients underwent long-course radiotherapy,the overall survival for 3 and 5 years were 91% and 78%, respectively. Conclusion: The sole characteristic of rectal cancer patients in Department of Radiotherapy atCipto Mangunkusumo Hospital that is different from previous studies is the age group wheremost patients were in. Stable disease is the most frequent radiation response. There was no correlation found between OTT and DTT with radiation response., Purpose: To obtain the profile of rectal cancer patients in Department of Radiotherapy, National General Hospital of Cipto Mangunkusumo.Method: A restrospective study was conducted over 144 rectal cancer patients undergone radiation therapy in Department of Radiotherapy, National General Hospital of CiptoMangunkusumo during period of January 2009 to January 2014. The characteristics ofpatients and tumour were assessed. The radiation response was evaluated with the RECIST1.1 method. The correlation between OTT and DTT with radiation response was analyzedwith Spearman’s correlation and the survival analysis was determined using Kaplan-Meiercurve. Result: The majority of patients were male (65.9%), with median age of 53 (23-81) years oldwhere most patients belonged to age group of 50-59 years old. The most frequenthistopathologic type found was adenocarcinoma (88.8%) with most patients were in stageIIIB (25.0%). Chemoradiation was performed in 29.8% of patients, and grade I skin toxicitywas the most frequent acute side effect of radiation found (20.1%). Radiation responseassessed with the RECIST 1.1 method showed stable disease as the mostly seen response(71.4%). There was no correlation found between OTT and DTT with radiation response.Overall survival from 118 patients for 3 and 5 years were 65% and 45%, respectively, withmedian survival of 59 months. In the group of patients underwent long-course radiotherapy,the overall survival for 3 and 5 years were 91% and 78%, respectively. Conclusion: The sole characteristic of rectal cancer patients in Department of Radiotherapy atCipto Mangunkusumo Hospital that is different from previous studies is the age group wheremost patients were in. Stable disease is the most frequent radiation response. There was no correlation found between OTT and DTT with radiation response.]"